This startup is using AI to give failed drugs a second chance. Check out the pitch deck it used to attract investors.
Ignota Labs leverages AI to revitalize failed drug candidates, increasing efficiency in the drug modification process and reducing costs significantly.
This startup is using AI to give failed drugs a second chance. Check out the pitch deck it used to attract investors.
Ignota Labs leverages AI to revitalize failed drug candidates, increasing efficiency in the drug modification process and reducing costs significantly.
The desire to stop your own tragedies from happening to someone else may be a strong motivator. However, the process of drug discovery has always been grindingly, gruelingly slow.
Modular arene functionalization by differential 1,2-diborylation - Nature
The introduction of diverse vicinal substituents to readily available precursors in small molecule drug development has been simplified by our novel nickel-catalyzed diborylation method.
Substrate recognition and cleavage mechanism of the monkeypox protease, Core protease
The structure of CorePro from poxviruses, crucial for viral maturation, has been determined, providing a target for potential antiviral drug development.
Hoffmann's discovery of LSD opened doors to understanding brain function and mental disorders, paving the way for future treatments of conditions like schizophrenia.